Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nordic Naturals donates, promotes for Haiti relief

This article was originally published in The Tan Sheet

Executive Summary

Omega-3 firm Nordic Naturals follows other drug and supplement firms' lead by donating 1 percent of some of its sales in February to help rebuild Haiti following the earthquake that devastated the country. The Watsonville, Calif., firm said Jan. 25 it will partner with the nonprofit Architecture for Humanity to make an "immediate donation" to Haiti through the American Red Cross. Products included in the campaign include Ultimate Omega and ProOmega. Abbott and Johnson & Johnson are among firms that previously announced they would provide money and medicines to help Haiti (1"The Tan Sheet" Jan. 18, 2010)

You may also be interested in...

Pharma, Supplement Firms Donate Products And Cash To Haiti Relief

The pharmaceutical and nutritional industries rallied to support relief efforts in Haiti

Mylan Weighs In On Coronavirus Drug Shortage Concerns

Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business. 


Eyes On Pricing As Zolgensma Moves Closer To Japan Market

Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts